These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8134338)

  • 1. Sequence-specific transcriptional activation is essential for growth suppression by p53.
    Pietenpol JA; Tokino T; Thiagalingam S; el-Deiry WS; Kinzler KW; Vogelstein B
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):1998-2002. PubMed ID: 8134338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of transactivation and transrepression function, and not RPA binding, alters growth suppression by p53.
    Leiter LM; Chen J; Marathe T; Tanaka M; Dutta A
    Oncogene; 1996 Jun; 12(12):2661-8. PubMed ID: 8700525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The strength of acidic activation domains correlates with their affinity for both transcriptional and non-transcriptional proteins.
    Melcher K
    J Mol Biol; 2000 Sep; 301(5):1097-112. PubMed ID: 10966808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional activation by DNA-binding derivatives of HSV-1 VP16 that lack the carboxyl-terminal acidic activation domain.
    Popova B; Bilan P; Xiao P; Faught M; Capone JP
    Virology; 1995 May; 209(1):19-28. PubMed ID: 7747469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
    Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
    Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity.
    Candau R; Scolnick DM; Darpino P; Ying CY; Halazonetis TD; Berger SL
    Oncogene; 1997 Aug; 15(7):807-16. PubMed ID: 9266967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of chromosomal DNA replication in Saccharomyces cerevisiae by acidic transcriptional activation domains.
    Li R; Yu DS; Tanaka M; Zheng L; Berger SL; Stillman B
    Mol Cell Biol; 1998 Mar; 18(3):1296-302. PubMed ID: 9488444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 amino acids 339-346 represent the minimal p53 repression domain.
    Hong TM; Chen JJ; Peck K; Yang PC; Wu CW
    J Biol Chem; 2001 Jan; 276(2):1510-5. PubMed ID: 11007800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 Tat binding protein-1 is a transcriptional coactivator specific for TR.
    Ishizuka T; Satoh T; Monden T; Shibusawa N; Hashida T; Yamada M; Mori M
    Mol Endocrinol; 2001 Aug; 15(8):1329-43. PubMed ID: 11463857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.
    Agostini I; Navarro JM; Rey F; Bouhamdan M; Spire B; Vigne R; Sire J
    J Mol Biol; 1996 Sep; 261(5):599-606. PubMed ID: 8800208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo requirement of activator-specific binding targets of mediator.
    Park JM; Kim HS; Han SJ; Hwang MS; Lee YC; Kim YJ
    Mol Cell Biol; 2000 Dec; 20(23):8709-19. PubMed ID: 11073972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wilms' tumor suppressor gene (wt1) product represses different functional classes of transcriptional activation domains.
    Lee TH; Moffett P; Pelletier J
    Nucleic Acids Res; 1999 Jul; 27(14):2889-97. PubMed ID: 10390530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GCN5 dependence of chromatin remodeling and transcriptional activation by the GAL4 and VP16 activation domains in budding yeast.
    Stafford GA; Morse RH
    Mol Cell Biol; 2001 Jul; 21(14):4568-78. PubMed ID: 11416135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activators direct histone acetyltransferase complexes to nucleosomes.
    Utley RT; Ikeda K; Grant PA; Côté J; Steger DJ; Eberharter A; John S; Workman JL
    Nature; 1998 Jul; 394(6692):498-502. PubMed ID: 9697775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.
    Shimada A; Kato S; Enjo K; Osada M; Ikawa Y; Kohno K; Obinata M; Kanamaru R; Ikawa S; Ishioka C
    Cancer Res; 1999 Jun; 59(12):2781-6. PubMed ID: 10383130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Useful vectors for the two-hybrid system in mammalian cells.
    Buchert M; Schneider S; Adams MT; Hefti HP; Moelling K; Hovens CM
    Biotechniques; 1997 Sep; 23(3):396-8, 400, 402. PubMed ID: 9298205
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
    Wang L; Grossman SR; Kieff E
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):430-5. PubMed ID: 10618435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators.
    Ito M; Yuan CX; Malik S; Gu W; Fondell JD; Yamamura S; Fu ZY; Zhang X; Qin J; Roeder RG
    Mol Cell; 1999 Mar; 3(3):361-70. PubMed ID: 10198638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
    Hansen RS; Braithwaite AW
    Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.